|
1
|
Perez JR, Kouroupis D, Li DJ, Best TM,
Kaplan L and Correa D: Tissue engineering and cell-based therapies
for fractures and bone defects. Front Bioeng Biotechnol. 6:1052018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Golpanian S, Wolf A, Hatzistergos KE and
Hare JM: Rebuilding the damaged heart: Mesenchymal stem cells,
cell-based therapy, and engineered heart tissue. Physiol Rev.
96:1127–1168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heathman TR, Nienow AW, McCall MJ, Coopman
K, Kara B and Hewitt CJ: The translation of cell-based therapies:
Clinical landscape and manufacturing challenges. Regen Med.
10:49–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leach JK and Whitehead J:
Materials-directed differentiation of mesenchymal stem cells for
tissue engineering and regeneration. ACS Biomater Sci Eng.
4:1115–1127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toyoda E, Sato M, Takahashi T, Maehara M,
Nakamura Y, Mitani G, Takagaki T, Hamahashi K and Watanabe M:
Multilineage-differentiating stress-enduring (Muse)-like cells
exist in synovial tissue. Regen Ther. 10:17–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hatakeyama A, Uchida S, Utsunomiya H,
Tsukamoto M, Nakashima H, Nakamura E, Pascual-Garrido C, Sekiya I
and Sakai A: Isolation and characterization of synovial mesenchymal
stem cell derived from hip joints: A comparative analysis with a
matched control knee group. Stem Cells Int. 2017:93123292017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng W, Gu X, Sun X, Wu Q and Dan H: FAK
mediates BMP9-induced osteogenic differentiation via Wnt and MAPK
signaling pathway in synovial mesenchymal stem cells. Artifl Cells
Nanomed Biotechnol. 47:2641–2649. 2019. View Article : Google Scholar
|
|
8
|
Baboolal TG, Khalil-Khan A, Theodorides
AA, Wall O, Jones E and McGonagle D: A novel arthroscopic technique
for intraoperative mobilization of synovial mesenchymal stem cells.
Am J Sports Med. 46:3532–3540. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Santhagunam A, Dos Santos F, Madeira C,
Salgueiro JB and Cabral JM: Isolation and ex vivo expansion of
synovial mesenchymal stromal cells for cartilage repair.
Cytotherapy. 16:440–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferro T, Santhagunam A, Madeira C,
Salgueiro JB, da Silva CL and Cabral JMS: Successful isolation and
ex vivo expansion of human mesenchymal stem/stromal cells obtained
from different synovial tissue-derived (biopsy) samples. J Cell
Physiol. 234:3973–3984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Segawa Y, Muneta T, Makino H, Nimura A,
Mochizuki T, Ju YJ, Ezura Y, Umezawa A and Sekiya I: Mesenchymal
stem cells derived from synovium, meniscus, anterior cruciate
ligament, and articular chondrocytes share similar gene expression
profiles. J Orthop Res. 27:435–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Juranek I, Stern R and Soltes L:
Hyaluronan peroxidation is required for normal synovial function:
An hypothesis. Med Hypotheses. 82:662–666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fearon U, Canavan M, Biniecka M and Veale
DJ: Hypoxia, mitochondrial dysfunction and synovial invasiveness in
rheumatoid arthritis. Nat Rev Rheumatol. 12:385–397. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schipani E, Mangiavini L and Merceron C:
HIF-1α and growth plate development: What we really know. Bonekey
Rep. 4:7302015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schönenberger MJ and Kovacs WJ: Hypoxia
signaling pathways: Modulators of oxygen-related organelles. Front
Cell Dev Biol. 3:422015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esteve JM, Launay JM, Kellermann O and
Maroteaux L: Functions of serotonin in hypoxic pulmonary vascular
remodeling. Cell Biochem Biophys. 47:33–44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patel J, Landers K, Mortimer RH and
Richard K: Regulation of hypoxia inducible factors (HIF) in hypoxia
and normoxia during placental development. Placenta. 31:951–957.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Acker T and Plate KH: Hypoxia and hypoxia
inducible factors (HIF) as important regulators of tumor
physiology. Cancer Treat Res. 117:219–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Warfel NA, Dolloff NG, Dicker DT, Malysz J
and El-Deiry WS: CDK1 stabilizes HIF-1α via direct phosphorylation
of Ser668 to promote tumor growth. Cell Cycle. 12:3689–3701. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alonso D, Serrano E, Bermejo FJ and Corral
RS: HIF-1α-regulated MIF activation and Nox2-dependent ROS
generation promote Leishmania amazonensis killing by macrophages
under hypoxia. Cell Immunol. 335:15–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu J, Zhang C, Zhao Y, Yue X, Wu H, Huang
S, Chen J, Tomsky K, Xie H, Khella CA, et al: Parkin targets HIF-1α
for ubiquitination and degradation to inhibit breast tumor
progression. Nat Commun. 8:18232017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mukund V, Saddala MS, Farran B,
Mannavarapu M, Alam A and Nagaraju GP: Molecular docking studies of
angiogenesis target protein HIF-1α and genistein in breast cancer.
Gene. 701:169–172. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Palmer CS, Ostrowski M, Balderson B,
Christian N and Crowe SM: Glucose metabolism regulates T cell
activation, differentiation, and functions. Front Immunol. 6:12015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho SH, Raybuck AL, Blagih J, Kemboi E,
Haase VH, Jones RG and Boothby MR: Hypoxia-inducible factors in
CD4+ T cells promote metabolism, switch cytokine
secretion, and T cell help in humoral immunity. Proc Natl Acad Sci
USA. 116:8975–8984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pfander D and Gelse K: Hypoxia and
osteoarthritis: How chondrocytes survive hypoxic environments. Curr
Opin Rheumatol. 19:457–462. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang SJ, Li W, Li YJ, Fang W and Long X:
Dickkopfrelated protein 1 induces angiogenesis by upregulating
vascular endothelial growth factor in the synovial fibroblasts of
patients with temporomandibular joint disorders. Mol Med Rep.
12:4959–4966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fleming AM, Zhu J, Ding Y and Burrows CJ:
Location dependence of the transcriptional response of a potential
G-quadruplex in gene promoters under oxidative stress. Nucleic
Acids Res. 47:5049–5060. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng W, Yang M, Wu C and Su X:
Experimental study on Osteogenesis of synovium-derived mesenchymal
stem cells in vitro and in vivo. Zhongguo Xiu Fu Chong Jian Wai Ke
Za Zhi. 30:102–109. 2016.(In Chinese). PubMed/NCBI
|
|
29
|
Lv B, Hua T, Li F, Han J, Fang J, Xu L,
Sun C, Zhang Z, Feng Z and Jiang X: Hypoxia-inducible factor 1 a
protects mesenchymal stem cells against oxygen-glucose
deprivation-induced injury via autophagy induction and
PI3K/AKT/mTOR signaling pathway. Am J Transl Res. 9:2492–2499.
2017.PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fernández-Torres J, Martínez-Nava GA,
Gutiérrez-Ruíz MC, Gómez-Quiroz LE and Gutiérrez M: Role of HIF-1α
signaling pathway in osteoarthritis: A systematic review. Rev Bras
Reumatol Engl Ed. 57:162–173. 2017.(In English, Portuguese).
PubMed/NCBI
|
|
32
|
Daniel SK, Sullivan KM, Labadie KP and
Pillarisetty VG: Hypoxia as a barrier to immunotherapy in
pancreatic adenocarcinoma. Clin Transl Med. 8:102019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ichihara S, Li P, Mise N, Suzuki Y, Izuoka
K, Nakajima T, Gonzalez F and Ichihara G: Ablation of aryl
hydrocarbon receptor promotes angiotensin II-induced cardiac
fibrosis through enhanced c-Jun/HIF-1α signaling. Arch Toxicol.
93:1543–1553. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Radenska-Lopovok SG: Immunomorphological
characteristics of the synovial membrane in rheumatic diseases.
Arkh Patol. 78:64–68. 2016.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sekiya I, Koga H, Otabe K, Nakagawa Y,
Katano H, Ozeki N, Mizuno M, Horie M, Kohno Y, Katagiri K, et al:
Additional use of synovial mesenchymal stem cell transplantation
following surgical repair of a complex degenerative tear of the
medial meniscus of the knee: A case report. Cell Transplant. Jul
17–2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Desando G, Bartolotti I, Cavallo C,
Schiavinato A, Secchieri C, Kon E, Filardo G, Paro M and Grigolo B:
Short-term homing of hyaluronan-primed cells: Therapeutic
implications for osteoarthritis treatment. Tissue Eng Part C
Methods. 24:121–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu W, Xu R, Li X, Zhang H, Wang X and Zhu
J: Downregulating hypoxia-inducible factor-1α expression with
perfluorooctyl-bromide nanoparticles reduces early brain injury
following experimental subarachnoid hemorrhage in rats. Am J Transl
Res. 8:2114–2126. 2016.PubMed/NCBI
|
|
38
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miska J, Lee-Chang C, Rashidi A, Muroski
ME, Chang AL, Lopez-Rosas A, Zhang P, Panek WK, Cordero A, Han Y,
et al: HIF-1α is a metabolic switch between glycolytic-driven
migration and oxidative phosphorylation-driven immunosuppression of
tregs in glioblastoma. Cell Rep. 27:226–237.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bensaad K and Harris AL: Hypoxia and
metabolism in cancer. Adv Exp Med Biol. 772:1–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao L, Mao Y, Zhao Y, Cao Y and Chen X:
Role of multifaceted regulators in cancer glucose metabolism and
their clinical significance. Oncotarget. 7:31572–31585.
2016.PubMed/NCBI
|
|
42
|
Pereira KM, Chaves FN, Viana TS, Carvalho
FS, Costa FW, Alves AP and Sousa FB: Oxygen metabolism in oral
cancer: HIF and GLUTs (Review). Oncol Lett. 6:311–316. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen Z, Tian D, Liao X, Zhang Y, Xiao J,
Chen W, Liu Q, Chen Y, Li D, Zhu L and Cai S: Apigenin combined
with gefitinib blocks autophagy flux and induces apoptotic cell
death through inhibition of HIF-1α, c-Myc, p-EGFR, and glucose
metabolism in EGFR L858R+T790M-mutated H1975 cells. Front
Pharmacol. 10:2602019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fu YC and Xin ZM: Inhibited corneal
neovascularization in rabbits following corneal alkali burn by
double-target interference for VEGF and HIF-1α. Biosci Rep.
39(pii): BSR201805522019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Szojka ARA, Lyons BD, Moore CN, Liang Y,
Kunze M, Idrees E, Mulet-Sierra A, Jomha NM and Adesida AB: Hypoxia
and TGF-β3 synergistically mediate inner meniscus-like matrix
formation by fibrochondrocytes. Tissue Eng Part A. 25:446–456.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Knowles HJ: Hypoxia-induced fibroblast
growth factor 11 stimulates osteoclast-mediated resorption of bone.
Calcif Tissue Int. 100:382–391. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao FL and Qin CF: EGF promotes HIF-1α
expression in colorectal cancer cells and tumor metastasis by
regulating phosphorylation of STAT3. Eur Rev Med Pharmacol Sci.
23:1055–1062. 2019.PubMed/NCBI
|
